Document is current
Any future updates will be listed below
-
Authors
Lin, Hanfeng https://orcid.org/0000-0002-3172-5616
Yang, Bin
Ding, Lang https://orcid.org/0000-0002-5365-9445
Yang, Yen-Yu
Holt, Matthew V.
Jung, Sung Yun https://orcid.org/0000-0003-1521-7977
Zhang, Bing https://orcid.org/0000-0001-8676-2425
Wang, Meng C. https://orcid.org/0000-0002-5898-6007
Wang, Jin https://orcid.org/0000-0003-3625-7919
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01-CA250503)
Cancer Prevention and Research Institute of Texas (RP220480)
- License Information
-
More Information
Article History
Received: 24 September 2024
Accepted: 21 August 2025
First Online: 30 September 2025
Competing interests
: The authors declare the following competing financial interest(s): J.W. is a co-founder of Chemical Biology Probes, LLC. and serves as a consultant for CoRegen Inc. J.W. and B.Y. are co-founders of Fortitude Biomedicines, Inc. and hold equity interest in this company. None of the conflicts of interests are related to this study. The remaining authors declare no competing interests.
